143 related articles for article (PubMed ID: 12670781)
41. Effect of single inhalation of a salbutamol, ipratropium bromide and beclomethasone on mucociliary clearance in patients with chronic obstructive airway disease.
Guleria R; Singh TR; Sinha S; Padhy K; Gupta K; Pande JN
Indian J Chest Dis Allied Sci; 2003; 45(4):241-6. PubMed ID: 12962458
[TBL] [Abstract][Full Text] [Related]
42. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.
Cuvelier A; Muir JF; Benhamou D; Weitzenblum E; Zuck P; Delacenserie R; Taytard A; Iacono P
Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
44. An overview of the pharmacokinetics of cilomilast (Ariflo), a new, orally active phosphodiesterase 4 inhibitor, in healthy young and elderly volunteers.
Zussman BD; Benincosa LJ; Webber DM; Clark DJ; Cowley H; Kelly J; Murdoch RD; Upward J; Wyld P; Port A; Fuder H
J Clin Pharmacol; 2001 Sep; 41(9):950-8. PubMed ID: 11549099
[TBL] [Abstract][Full Text] [Related]
45. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease.
Dahl R; Greefhorst LA; Nowak D; Nonikov V; Byrne AM; Thomson MH; Till D; Della Cioppa G;
Am J Respir Crit Care Med; 2001 Sep; 164(5):778-84. PubMed ID: 11549532
[TBL] [Abstract][Full Text] [Related]
46. A randomized, placebo-controlled, double-blind trial on the management of post-infective cough by inhaled ipratropium and salbutamol administered in combination.
Zanasi A; Lecchi M; Del Forno M; Fabbri E; Mastroroberto M; Mazzolini M; Pisani L; Pandolfi P; Nava S; Morselli-Labate AM
Pulm Pharmacol Ther; 2014 Dec; 29(2):224-32. PubMed ID: 25111667
[TBL] [Abstract][Full Text] [Related]
47. A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence.
Easton PA; Jadue C; Dhingra S; Anthonisen NR
N Engl J Med; 1986 Sep; 315(12):735-9. PubMed ID: 2943994
[TBL] [Abstract][Full Text] [Related]
48. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
Ikeda A; Nishimura K; Koyama H; Izumi T
Chest; 1995 Feb; 107(2):401-5. PubMed ID: 7842768
[TBL] [Abstract][Full Text] [Related]
49. Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate-to-severe persistent asthma.
Gelb AF; Karpel J; Wise RA; Cassino C; Johnson P; Conoscenti CS
Pulm Pharmacol Ther; 2008 Aug; 21(4):630-6. PubMed ID: 18403223
[TBL] [Abstract][Full Text] [Related]
50. Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease.
Burdet L; de Muralt B; Schutz Y; Fitting JW
Thorax; 1997 Feb; 52(2):130-5. PubMed ID: 9059472
[TBL] [Abstract][Full Text] [Related]
51. Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease.
Gordon J; Panos RJ
Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):381-92. PubMed ID: 20163324
[TBL] [Abstract][Full Text] [Related]
52. [A comparison of bronchodilating drugs in the treatment of stable COPD].
Nishimura K; Koyama H; Izumi T
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):835-43. PubMed ID: 1385837
[TBL] [Abstract][Full Text] [Related]
53. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
[TBL] [Abstract][Full Text] [Related]
54. A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD.
Oga T; Nishimura K; Tsukino M; Sato S; Hajiro T; Mishima M
Chest; 2003 Jun; 123(6):1810-6. PubMed ID: 12796154
[TBL] [Abstract][Full Text] [Related]
55. The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study.
Make B; Hanania NA; ZuWallack R; Kalberg C; Emmett A; Brown CP; Knobil K
Clin Ther; 2005 May; 27(5):531-42. PubMed ID: 15978302
[TBL] [Abstract][Full Text] [Related]
56. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
57. The role of domiciliary nebulizers in managing patients with severe COPD.
Eiser N; Angus K; McHale S
Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
[TBL] [Abstract][Full Text] [Related]
58. [Effects of inhaled short-acting bronchodilators on diaphragm function and neural respiratory drive during maximal isocapnic ventilation in patients with chronic obstructive pulmonary disease].
Li Y; Li YH; Luo YW; Xiao R; Huang JL; Wang K; Chen X
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 36(2):232-7. PubMed ID: 26922022
[TBL] [Abstract][Full Text] [Related]
59. Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD).
Grootendorst DC; Gauw SA; Benschop N; Sterk PJ; Hiemstra PS; Rabe KF
Pulm Pharmacol Ther; 2003; 16(6):341-7. PubMed ID: 14580925
[TBL] [Abstract][Full Text] [Related]
60. Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonist.
Cazzola M; Boveri B; Carlucci P; Santus P; DiMarco F; Centanni S; Allegra L
Pulm Pharmacol Ther; 2000; 13(6):301-5. PubMed ID: 11061985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
